Date Field | Doc. No. | Description (Pages) |
---|
May 6, 2019 | 15 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [605101] [17-1240, 17-1455, 17-1887] [PBC] [Entered: 05/06/2019 10:54 AM] (2) |
Mar 28, 2019 | 13 | OPINION filed for the court by Wallach, Circuit Judge; Clevenger, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. [596105] [17-1240, 17-1455, 17-1887] [PBC] [Entered: 03/28/2019 09:42 AM] (17) |
Mar 28, 2019 | 14 | JUDGMENT filed. REVERSED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellee(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [596106] [17-1240, 17-1455, 17-1887] [PBC] [Entered: 03/28/2019 09:43 AM] (2) |
Mar 15, 2018 | 12 | Note to file: The following cases are consolidated: 17-1240 (Lead) with 17-1455 and 17-1887 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [505708] [17-1240, 17-1455, 17-1887] [MJL] [Entered: 03/15/2018 04:30 PM] (0) |
Apr 12, 2017 | 10 | ORDER consolidating appeals (17-1887 with 17-1094, -1240, -1444, -1455). The revised official caption is reflected in the order. Endo Pharmaceuticals Inc.'s opening brief addressing all of these appeals, and Mallinckrodt LLC's response brief addressing only issues associated with 17-1094, -1240, -1444, -1455, are due no later than 05/01/2017. Amneal Pharmaceuticals LLC et al.'s response/reply brief, addressing only issues associated with 17-1094, -1240, -1444, -1455, and Actavis LLC et al.'s response brief, addressing only issues associated with 17-1887, are due no later than 06/12/2017. Endo's reply brief is due no later than 06/26/2017. Service as of this date by Clerk of Court. [423414] [17-1094, 17-1240, 17-1444, 17-1455, 17-1887] [MJL] [Entered: 04/12/2017 11:52 AM] (2) |
Apr 12, 2017 | 11 | Note to file: The following cases are consolidated: 17-1094 (Lead) with 17-1240, -1444, -1455, -1887 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [423608] [17-1094, 17-1240, 17-1444, 17-1455, 17-1887] [MJL] [Entered: 04/12/2017 04:33 PM] (0) |
Mar 10, 2017 | 9 | Note to file: The following cases are associated:17-1094 Lead with 17-1240, 17-1444, 17-1455 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [414391] [17-1094, 17-1240, 17-1444, 17-1455] [JCA] [Entered: 03/10/2017 01:13 PM] (0) |
Jan 18, 2017 | 3 | Entry of appearance for Jeffrey J. Toney as principal counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399906] [Jeffrey Toney] [Entered: 01/18/2017 11:54 AM] (2) |
Jan 18, 2017 | 4 | Entry of appearance for Rodney R. Miller as of counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399915] [Rodney Miller] [Entered: 01/18/2017 11:57 AM] (2) |
Jan 18, 2017 | 5 | Entry of appearance for Paul G. Williams as of counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399920] [Paul Williams] [Entered: 01/18/2017 12:00 PM] (2) |
Jan 18, 2017 | 6 | Certificate of Interest for the Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399922] [Jeffrey Toney] [Entered: 01/18/2017 12:02 PM] (3) |
Jan 18, 2017 | 7 | Docketing Statement for the Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399925] [Jeffrey Toney] [Entered: 01/18/2017 12:05 PM] (4) |
Jan 18, 2017 | 8 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Appellee's entries of appearance, certificate of interest, and docketing statement (Nos. [3], [4], [5], [6], & [7]) are filed in the consolidated cross-appeal docket. CORRECTION: Documents should be added to the lead appeal only. Refiling the listed documents is unnecessary, since they were also filed in the lead. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [399954] [CMP] [Entered: 01/18/2017 01:19 PM] (0) |
Jan 6, 2017 | 1 | Appeal docketed. Received: 01/05/2017. [396773] [MJL] [Entered: 01/06/2017 02:09 PM] (35) |
Jan 6, 2017 | 2 | Note to file: The following cases are consolidated: 17-1444 (Lead) with 17-1455 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [396776] [17-1444, 17-1455] [MJL] [Entered: 01/06/2017 02:14 PM] (0) |